All-cause mortality of patients with dyslipidemia up to 19 years after a multidisciplinary lifestyle modification programme: A randomized trial

European Journal of Preventive Cardiology

Volumn 18, Issue 1, 2011, Pages 79-85

  Häglin, Lena ^a   Lundström, Sara ^a,b   Kaati, Gunnar ^a   Bäckman, Lennart ^a   Bygren, Lars Olov ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

All cause mortality; dyslipidemia; intervention; secondary prevention

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; EXERCISE; FEMALE; FOOD PREFERENCE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STROKE;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DIET; DYSLIPIDEMIAS; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICES; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959221534     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32833a65cc     Document Type: Article

References (18)

1. Lauritzen T, Jensen MS, Thomsen JL, Christensen B, Engberg M. Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scand J Public Health 2008; 36: 650–661.
2. Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239–246.
3. Lichtenstein AH, Apple LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82–96.
4. Mendivil CO, Cortés E, Sierra ID, Ramirez A, Molano LM, Tovar LE, et al. Reduction of global cardiovascular risk with nutritional versus nutritional plus physical activity intervention in Colombian adults. Eur J Cardiovasc Prev Rehabil 2006; 13: 947–955.
5. Kaati G, Sjöström M, Vester M. The quality and use of knowledge in health policy-making: a case study. Critical Public Health 2004; 14: 225–237.
6. Kaati G, Vester M, Sjöström M, Bygren LO. Patients attachment patterns and response to a program for alleviating cardiovascular risk factors: a 1-year follow-up of patients in a patient education program. Patient Educ Couns 2001; 44: 235–241.
7. Matarazzo JD, Weiss SM, Herd JA, Miller NE, Weiss SM. Behavioral health. A handbook of health enhancement and disease prevention. New York: Johne Wiley & Sons, 1984.
8. Collett D. Modelling survival data in medical research. London: Chapman & Hal, 1994.
9. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular and all-cause mortality and to longevity. JAMA 2000; 284: 311–318.
10. Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003; 253: 169–180.
11. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998; 339: 12–20.
12. Van Dam RM, Li T, Spiegelman D, Franco OH, Hu FB. Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ 2008; 337: a1440–a1440.
13. Tankó LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005; 111: 1883–1890.
14. Ali YS, Linton MF, Fazio S. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia. Curr Opin Endocrinol Diabetes Obes 2008; 15: 142–146.
15. Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardio vascular mortality in young (<55 years) men and women. Eur Heart J 2002; 23: 528–535.
16. Håglin L, Törnkvist B, Bäckman L. Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and -magnesium. Acta Diabetol 2007; 44: 138–143.
17. Håglin L, Lindblad Å, Bygren LO. Hypophosphataemia in the metabolic syndrome. Gender differences in body weight and blood glucose. Eur J Clin Nutr 2001; 55: 493–498.
18. Gannon MC, Nuttall FQ. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 2004; 53: 2375–2382.